0001415889-16-006297.txt : 20160621 0001415889-16-006297.hdr.sgml : 20160621 20160621213544 ACCESSION NUMBER: 0001415889-16-006297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160619 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-244-9990 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singh Shawn CENTRAL INDEX KEY: 0001412071 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 161725521 MAIL ADDRESS: STREET 1: C/O VISTAGEN THERAPEUTICS, INC. STREET 2: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4-06212016_060634.xml X0306 4 2016-06-19 0001411685 VistaGen Therapeutics, Inc. VTGN 0001412071 Singh Shawn C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 true true false false CHIEF EXECUTIVE OFFICER Stock Option (Right to Buy) 3.49 2016-06-19 4 A 0 200000 0 A 2026-06-19 Common Stock 200000 200000 D The Reporting Person's ability to exercise 75,000 of the options reported herein is conditioned upon stockholder approval of an amendment to the Issuer's 2008 Stock Incentive Plan. 25% of the shares subject to the option shall vest on the one year anniversary of the Grant Date and 1/48th of the shares subject to the option shall vest monthly every month thereafter until all awarded shares are fully vested. /s/ Jerrold D. Dotson, Attorney-in-Fact 2016-06-21